Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika

Saved in:
Bibliographic Details
Published in:Journal of clinical virology 2016-09, Vol.82, p.S49-S49
Main Authors: Plachot, C, Huang, C, Vemula, R, Wu, J, Lee, H.J, Anekella, B
Format: Article
Language:English
Subjects:
Allergy and Immunology
Infectious Disease
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2956-6ee6c1db4c739a447a7e9ed23544c39ce90c48725c0040b3bffa17c7313205f03
cites
container_end_page S49
container_issue
container_start_page S49
container_title Journal of clinical virology
container_volume 82
creator Plachot, C
Huang, C
Vemula, R
Wu, J
Lee, H.J
Anekella, B
description
doi_str_mv 10.1016/j.jcv.2016.08.096
format article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7128369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1386653216302888</els_id><sourcerecordid>1_s2_0_S1386653216302888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2956-6ee6c1db4c739a447a7e9ed23544c39ce90c48725c0040b3bffa17c7313205f03</originalsourceid><addsrcrecordid>eNp9UtuO0zAQjRBILAsfwJs_oCl2nKuQVkKlu1RaQGJZHnixnMkkcZt6Kjsp6mfxhzgKQoIHnnysmXM0Z85E0WvB14KL_M1-vYfzOglwzcs1r_In0ZUoCxlnVV48DViWeZxnMnkevfB-z7nIZFpcRT8fPTJqmUOgY22stiM7Gzd5NiL0lgbqLmwkdnLUTIDMko2NbRFGQ5NfsR89DThXAb1nQHZ0NHjWkmN4RNcZ2y166JmfoGfas21Ng16xTW8Ok-0mewmf9xgQxsmKfSJHywR3u92Kfdx-eYg39I1p27Dv5qBfRs9aPXh89fu9jh5vt183H-L7z3e7zbv7GJIqC14RcxBNnUIhK52mhS6wwiaRWZqCrAArDmlZJBlwnvJa1m2rRRGahUx41nJ5Hd0suqepPmIDGKzpQZ2cOWp3UaSN-rtiTa86OqtCJKXMqyAgFgFw5L3D9g9XcDWHpvYqhKbm0BQvVQgtcN4uHAzOzgad8mDQAjYmJDSqhsx_2Tf_sGEw1oAeDnhBv6fJ2bAyJZRPFFcP81HMNyFyyZOyLOUvkn64dA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Plachot, C ; Huang, C ; Vemula, R ; Wu, J ; Lee, H.J ; Anekella, B</creator><creatorcontrib>Plachot, C ; Huang, C ; Vemula, R ; Wu, J ; Lee, H.J ; Anekella, B</creatorcontrib><identifier>ISSN: 1386-6532</identifier><identifier>EISSN: 1873-5967</identifier><identifier>DOI: 10.1016/j.jcv.2016.08.096</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Allergy and Immunology ; Infectious Disease</subject><ispartof>Journal of clinical virology, 2016-09, Vol.82, p.S49-S49</ispartof><rights>2016</rights><rights>Copyright © 2016 Published by Elsevier B.V. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2956-6ee6c1db4c739a447a7e9ed23544c39ce90c48725c0040b3bffa17c7313205f03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Plachot, C</creatorcontrib><creatorcontrib>Huang, C</creatorcontrib><creatorcontrib>Vemula, R</creatorcontrib><creatorcontrib>Wu, J</creatorcontrib><creatorcontrib>Lee, H.J</creatorcontrib><creatorcontrib>Anekella, B</creatorcontrib><title>Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika</title><title>Journal of clinical virology</title><subject>Allergy and Immunology</subject><subject>Infectious Disease</subject><issn>1386-6532</issn><issn>1873-5967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9UtuO0zAQjRBILAsfwJs_oCl2nKuQVkKlu1RaQGJZHnixnMkkcZt6Kjsp6mfxhzgKQoIHnnysmXM0Z85E0WvB14KL_M1-vYfzOglwzcs1r_In0ZUoCxlnVV48DViWeZxnMnkevfB-z7nIZFpcRT8fPTJqmUOgY22stiM7Gzd5NiL0lgbqLmwkdnLUTIDMko2NbRFGQ5NfsR89DThXAb1nQHZ0NHjWkmN4RNcZ2y166JmfoGfas21Ng16xTW8Ok-0mewmf9xgQxsmKfSJHywR3u92Kfdx-eYg39I1p27Dv5qBfRs9aPXh89fu9jh5vt183H-L7z3e7zbv7GJIqC14RcxBNnUIhK52mhS6wwiaRWZqCrAArDmlZJBlwnvJa1m2rRRGahUx41nJ5Hd0suqepPmIDGKzpQZ2cOWp3UaSN-rtiTa86OqtCJKXMqyAgFgFw5L3D9g9XcDWHpvYqhKbm0BQvVQgtcN4uHAzOzgad8mDQAjYmJDSqhsx_2Tf_sGEw1oAeDnhBv6fJ2bAyJZRPFFcP81HMNyFyyZOyLOUvkn64dA</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Plachot, C</creator><creator>Huang, C</creator><creator>Vemula, R</creator><creator>Wu, J</creator><creator>Lee, H.J</creator><creator>Anekella, B</creator><general>Elsevier B.V</general><general>Published by Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20160901</creationdate><title>Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika</title><author>Plachot, C ; Huang, C ; Vemula, R ; Wu, J ; Lee, H.J ; Anekella, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2956-6ee6c1db4c739a447a7e9ed23544c39ce90c48725c0040b3bffa17c7313205f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Allergy and Immunology</topic><topic>Infectious Disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Plachot, C</creatorcontrib><creatorcontrib>Huang, C</creatorcontrib><creatorcontrib>Vemula, R</creatorcontrib><creatorcontrib>Wu, J</creatorcontrib><creatorcontrib>Lee, H.J</creatorcontrib><creatorcontrib>Anekella, B</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Plachot, C</au><au>Huang, C</au><au>Vemula, R</au><au>Wu, J</au><au>Lee, H.J</au><au>Anekella, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika</atitle><jtitle>Journal of clinical virology</jtitle><date>2016-09-01</date><risdate>2016</risdate><volume>82</volume><spage>S49</spage><epage>S49</epage><pages>S49-S49</pages><issn>1386-6532</issn><eissn>1873-5967</eissn><pub>Elsevier B.V</pub><doi>10.1016/j.jcv.2016.08.096</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1386-6532
ispartof Journal of clinical virology, 2016-09, Vol.82, p.S49-S49
issn 1386-6532
1873-5967
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7128369
source ScienceDirect Freedom Collection 2022-2024
subjects Allergy and Immunology
Infectious Disease
title Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A34%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20recombinant%20virus%20technology%20to%20produce%20non-infectious,%20whole%20process%20controls%20for%20emerging%20viruses%20such%20as%20Ebola,%20Chikungunya,%20Dengue-2,%20Norovirus%20GII,%20MERS-CoV%20and%20Zika&rft.jtitle=Journal%20of%20clinical%20virology&rft.au=Plachot,%20C&rft.date=2016-09-01&rft.volume=82&rft.spage=S49&rft.epage=S49&rft.pages=S49-S49&rft.issn=1386-6532&rft.eissn=1873-5967&rft_id=info:doi/10.1016/j.jcv.2016.08.096&rft_dat=%3Celsevier_pubme%3E1_s2_0_S1386653216302888%3C/elsevier_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2956-6ee6c1db4c739a447a7e9ed23544c39ce90c48725c0040b3bffa17c7313205f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true